| Tag | Content |
|---|
EnhancerAtlas ID | HS131-04440 |
Organism | Homo sapiens |
Tissue/cell | ME-1 |
Coordinate | chr19:8258730-8260780 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| ZNF263 | MA0528.1 | chr19:8260501-8260522 | TTCCCATCCTCTGCCTCCCCC | - | 6.62 | | ZNF263 | MA0528.1 | chr19:8260507-8260528 | TCCTCTGCCTCCCCCTCCTCC | - | 8.63 |
|
| | Number of super-enhancer constituents: 1 | ID | Coordinate | Tissue/cell |
| SE_11753 | chr19:8255554-8262522 | CD20 |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH19I008192 | chr19 | 8256886 | 8260773 |
|
Enhancer Sequence | CAAAATAAGA GACAAAGCTC TGAGTCAAAT GCAAAAGTTT AGATGCTCAC TCCATGGTCC 60
TTTCCTCCAG GGAAGTCCCC ACTCCCTGAG CCACCCCAGG GGACTCCTGG GCTGGAAAGA 120
ACTGAGAAAC CCCAGGCCTC TTGCTCCTCC AGAGTTGCAG GGGGACAAGG CAGAAACCCC 180
AAAGGTCCCG AGACCCTGAG CTTGGACACT GCCCCTCTTT TCCTGCAGCC TCTTCCTGTG 240
TCCCCAGCCC TGCACTCCCA TCCCCTCCCC CAACTCTGCT GGCCCAGCCC TGGCCTCCCT 300
CCCGCACTCA TTTCCGGAGG ATGCCCCAGC CTGTTGCAGA CATGGGGGAA GTCCAGCCTA 360
GTTGGGGATG TCACAAGGGG GTGGGGTTAG GGCTATTTCT TTTATTTTTT ATTTTTTTAT 420
TTTTTTATTT TTTTTGAGAT GGAGTCTCGC TCTGTCACCC AGGCTGGAGT GCAGTGGCAC 480
CATCTCGGCT CACTGCAACC TCTGCTTCCC GGGTTCAAGC AATTATCCTG CCTTAACCTC 540
CCGAGTAGCT GGGATTACAG GCACACGCCG CCACGCCCGG CTAATTTTTT GTATTTTAGT 600
AGAGATAGGG TTTCACCGTG TTGCCCAGGC TGGTATCGAA CTCCTGAACT CAGGCAATCT 660
GCCCACCTCA GCCTCCCAAA GTGCTAAGAT TACAGGCATG AGCCACCGTG CCCAGTCAGG 720
GCTGTCTTAT GTCTAGTTCA TACTCTAAAT GTTCAGACTT GACATGCCCC AGCCTATCTC 780
CAGCCACCCT CCTCCACCGC CCAGCCCGGC AGCCCACATC CTCACTGACA CGGATATCAG 840
GCAGGCTTCC TTCAAGACCG CTGTTTTTGC CCGTTCTCAA CTAGAGCCCA TAGCCTTGCT 900
CAGACACACA GGCTTGGAAG GCCACTAACT CACTGCCAGA CCTTGGGCAA GTCGCTCCAC 960
CTCCCTGATC CTGCCCTTCT GCATCTAAAA AGTGAAGTAT TAAAGGAAAA TGCATCTGTC 1020
TGCACGAAAG CAGAAACACA GCTCCTAGGT TCTGGTTCCA GCGGCTCACA GGCTGTGTGA 1080
CTTTGGGCCA GTGTCCTAAC CTCTCTGGGC TTCGGTTTCC TCACCTGTCA AAGAGGAATT 1140
AAGAGGACCC ACCTCACAAG GCTGTTGCAG GATCAGATGA GTTCATTTCA AATAGTGTCT 1200
GCAGCCTGAG CAACTTAGTG GGACCCCATC TCTAACAAAA TTTAAAATGT GGCATGAACC 1260
TGTAGTCCCA GCTACTTGGG AGGCTGAAGA TGGCTTGAGC CTGAGAGCTG GAGGTTGCAG 1320
TGAGCTATGA TTATGCCACT GTACTCCAGC CTGGGCAACA GAGTGAGACC CTGTCTTTTT 1380
TTTTTTTTTT TTTTTTTTTG TGACAGAGTC TCACTCTATC GCCCAGGCTG GAGTACAGTG 1440
GCATGAGAGA TGAAACACAC CCCAACCAGG TGTCTGCCTT GCAGCTGGGA CTAGCTTCTC 1500
CCCATACTTC CTCCTGTCTT TACCCAAGGG GCCTTCAACT ACCGTGCACC TCCCTTCTGA 1560
GCAGACACCA AGGACATCCT GTCTCCAGCC CAGACACACA CTCTGAGCTT CCTCTATGTG 1620
CACCTCCCAC AGCCCCCTGG AGATCTGCAC CTTCTAACAT CCAATGCCAC ATCTTCCCTC 1680
CAGATCTGCT TTCACCCTGT GCTCCCTGCC CAGAGATGGG CACCGAGCCA GGCCCGCCTG 1740
CCCAGCATAG TCCAGGCCTG GGGGGTAGAC CTTCCCATCC TCTGCCTCCC CCTCCTCCCT 1800
TCCCTGGGTC CCCCAGACTC CAGACACCCT CATCTCGGAA CCGGACTCTG TTTTGCTCCG 1860
TTCTCTCCAC TCACCTCCCA CCCTGCAGCC CTGGTCACTC TATTTTTTTT TTTTTTGAGA 1920
CGGATTCTCG CTCTGTCACC CAGGCTGGAG TGCAGTGGCG CGATCTTGGC TCACTGCAAG 1980
CTCCGCCTCC CGGGTTCACA CCATTCTCCT GCCTTAGCCT CCGGAGTAGC TGGGACTACA 2040
GGTGCCCACC 2050
|
